ROSEN, NATIONAL TRIAL LAWYERS, Encourages PROCEPT BioRobotics Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – PRCT

Rosen Law Firm has filed a securities class action lawsuit against PROCEPT BioRobotics Corporation on behalf of investors who purchased common stock between February 28, 2024 and February 25, 2026. The lawsuit alleges that PROCEPT made materially false statements regarding its handpiece unit sales and revenues by utilizing an undisclosed discount program that artificially inflated sales figures and created excess inventory of over 10,000 units. The firm claims the company's 2025 guidance lacked a reasonable factual basis. Investors must move the court by September 22, 2026 to serve as lead plaintiff.

07/31/2026, 9:27 PM • GlobeNewswire

The Gross Law Firm Reminds PROCEPT BioRobotics Corporation Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2026 - PRCT

A class action lawsuit has been filed against PROCEPT BioRobotics Corporation alleging the company issued materially false statements regarding its handpiece unit sales and revenues. The complaint claims PROCEPT used an undisclosed discount program to artificially inflate sales figures, created excess field inventory of over 10,000 units, and failed to disclose material risks. The lead plaintiff deadline is September 22, 2026.

07/31/2026, 10:27 AM • GlobeNewswire

HELE DEADLINE: The Gross Law Firm Reminds Helen of Troy Limited Investors of Upcoming Securities Class Action Deadline

The Gross Law Firm has announced securities class action lawsuits against Helen of Troy Limited (HELE) and other companies for allegedly making false and misleading statements. HELE is accused of misrepresenting the expected savings and effectiveness of Project Pegasus. The deadline for shareholders to register as potential lead plaintiffs is August 3, 2026.

07/31/2026, 10:27 AM • GlobeNewswire

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit - PODD

The Gross Law Firm has issued notices regarding multiple securities class action lawsuits. Insulet Corporation faces allegations of defective manufacturing controls and misleading statements regarding product safety, with a lead plaintiff deadline of August 31, 2026. Similar class action notices were issued for PROCEPT BioRobotics Corporation and Helen of Troy Limited, with deadlines in September 2026.

07/31/2026, 10:23 AM • GlobeNewswire

PROCEPT BioRobotics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against PROCEPT BioRobotics Corporation - PRCT

PROCEPT BioRobotics faces a securities class action lawsuit for allegedly failing to disclose material information about excess handpiece inventory and inflated sales figures during the Class Period (February 28, 2024 - February 25, 2026). Investors with losses exceeding $100,000 have until September 22, 2026 to file lead plaintiff applications.

07/30/2026, 11:55 AM • GlobeNewswire

PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

PROCEPT BioRobotics faces a securities class action lawsuit for failing to disclose material inventory issues. The company revealed on February 25, 2026 that handpiece sales had materially exceeded procedures since Q1 2023, resulting in over 10,000 units of excess field inventory. This disclosure caused the stock to decline approximately 18% in two days, from $27.84 to $22.69 per share. Investors who purchased shares between February 28, 2024 and February 25, 2026 can file lead plaintiff applications by September 22, 2026.

07/28/2026, 11:38 PM • GlobeNewswire

Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Law firm Kahn Swick & Foti, LLC has filed multiple class action securities lawsuits against Erasca, Inc., EquipmentShare.com Inc., and PROCEPT BioRobotics Corporation. Erasca faces allegations of failing to disclose material information regarding its ERAS-0015 product and improper patent comparisons. EquipmentShare.com and PROCEPT BioRobotics also face securities fraud claims. Investors have until specified deadlines to apply as lead plaintiffs.

07/28/2026, 11:33 PM • GlobeNewswire

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages PROCEPT BioRobotics Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – PRCT

Rosen Law Firm has filed a class action lawsuit against PROCEPT BioRobotics Corporation on behalf of investors who purchased common stock between February 28, 2024 and February 25, 2026. The lawsuit alleges that PROCEPT made materially false statements regarding its handpiece unit sales and revenues by utilizing an undisclosed discount program that artificially inflated sales figures and created excess inventory of over 10,000 units. The company allegedly failed to disclose these risks and was unable to achieve its 2025 guidance. Investors must move the court by September 22, 2026 to serve as lead plaintiff.

07/28/2026, 7:21 PM • GlobeNewswire

Notice to Long-Term Shareholders of Cogent Communications Holdings, Inc. (NASDAQ: CCOI); EquipmentShare.com, Inc. (NASDAQ: EQPT); Photronics, Inc. (NASDAQ: PLAB); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your Behalf

Grabar Law Office has initiated investigations on behalf of shareholders of four NASDAQ-listed companies: Cogent Communications (CCOI), EquipmentShare (EQPT), Photronics (PLAB), and PROCEPT BioRobotics (PRCT). The investigations allege breaches of fiduciary duties, including misrepresentation of business fundamentals, undisclosed related-party transactions, false demand statements, and artificially inflated sales figures. Shareholders who purchased shares before specified dates and still hold them may seek corporate reforms and damages at no cost.

07/27/2026, 1:56 PM • GlobeNewswire

PROCEPT BIOROBOTICS CORPORATION (PRCT) INVESTOR ALERT Investors With Large Losses in PROCEPT BioRobotics Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights

A securities class action lawsuit has been filed against PROCEPT BioRobotics Corporation on behalf of investors who purchased stock between February 28, 2024 and February 25, 2026. The lawsuit alleges the company made materially false and misleading statements regarding business operations, growth prospects, and financial stability, causing stock prices to trade at artificially inflated levels. Investors suffered significant losses when the truth was disclosed.

07/27/2026, 11:57 AM • GlobeNewswire

INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Intuit Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - INTU

Law firm Robbins Geller has announced class action lawsuits against Intuit Inc. for allegedly making false statements about competitive advantages and TurboTax revenue growth, resulting in a 20% stock drop after weak Q3 results. The firm is also filing cases against EquipmentShare.com and PROCEPT BioRobotics for similar securities fraud allegations.

07/27/2026, 5:40 AM • GlobeNewswire

PRCT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead the Procept Class Action Lawsuit

A class action lawsuit has been filed against PROCEPT BioRobotics Corporation, alleging that the company and its executives made materially false and misleading statements regarding sales practices. The lawsuit claims PROCEPT used undisclosed discount programs that artificially inflated handpiece unit sales and revenues, created excess field inventory of over 10,000 units, and issued unrealistic guidance. Stock price declined significantly following earnings announcements in August 2025, November 2025, and February 2026.

07/24/2026, 6:45 PM • GlobeNewswire

Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

A securities fraud investigation into PROCEPT BioRobotics Corporation continues following the company's February 25, 2026 earnings report, which disclosed larger-than-expected adjusted EBITDA losses and cut full-year 2026 revenue guidance from $410-$430 million to $390-$410 million. The stock fell $4.21 per share (15.12%) to $23.63 on the news. The law firm is seeking investors who lost money to participate in potential claims.

04/22/2026, 5:00 PM • Benzinga

Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz is investigating PROCEPT BioRobotics Corporation for possible federal securities law violations. On February 25, 2026, the company reported larger-than-expected adjusted EBITDA losses and cut its 2026 revenue guidance from $410-430 million to $390-410 million, citing reduced U.S. consumable revenue due to elimination of bulk purchase discounts. The stock fell $4.21 per share (15.12%) to $23.63 on the news.

04/22/2026, 2:07 PM • Benzinga

Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

A securities fraud investigation has been launched into PROCEPT BioRobotics (NASDAQ: PRCT) following the company's February 25, 2026 earnings report, which disclosed larger-than-expected adjusted EBITDA losses and a significant downward revision of full-year 2026 revenue guidance from $410-$430 million to $390-$410 million. The announcement triggered a 15.12% stock price decline ($4.21 per share) on February 26, 2026.

03/10/2026, 2:00 PM • Benzinga